Evaxion Biotech AS (EVAX)
1.37
-0.03
(-2.14%)
USD |
NASDAQ |
Nov 21, 16:00
1.37
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Market Cap: 8.037M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 8.212M |
| November 19, 2024 | 9.150M |
| November 18, 2024 | 9.562M |
| November 15, 2024 | 8.447M |
| November 14, 2024 | 9.855M |
| November 13, 2024 | 10.32M |
| November 12, 2024 | 13.96M |
| November 11, 2024 | 14.20M |
| November 08, 2024 | 14.67M |
| November 07, 2024 | 15.37M |
| November 06, 2024 | 15.08M |
| November 05, 2024 | 15.31M |
| November 04, 2024 | 15.49M |
| November 01, 2024 | 15.19M |
| October 31, 2024 | 15.66M |
| October 30, 2024 | 16.19M |
| October 29, 2024 | 17.07M |
| October 28, 2024 | 16.66M |
| October 25, 2024 | 16.19M |
| October 24, 2024 | 15.55M |
| October 23, 2024 | 15.33M |
| October 22, 2024 | 14.70M |
| October 21, 2024 | 14.58M |
| October 18, 2024 | 15.16M |
| October 17, 2024 | 15.56M |
| Date | Value |
|---|---|
| October 16, 2024 | 15.56M |
| October 15, 2024 | 14.93M |
| October 14, 2024 | 15.45M |
| October 11, 2024 | 14.93M |
| October 10, 2024 | 15.10M |
| October 09, 2024 | 15.39M |
| October 08, 2024 | 16.31M |
| October 07, 2024 | 16.36M |
| October 04, 2024 | 16.94M |
| October 03, 2024 | 17.57M |
| October 02, 2024 | 17.11M |
| October 01, 2024 | 16.82M |
| September 30, 2024 | 17.86M |
| September 27, 2024 | 17.74M |
| September 26, 2024 | 17.40M |
| September 25, 2024 | 16.09M |
| September 24, 2024 | 16.57M |
| September 23, 2024 | 16.46M |
| September 20, 2024 | 16.68M |
| September 19, 2024 | 17.57M |
| September 18, 2024 | 17.40M |
| September 17, 2024 | 16.90M |
| September 16, 2024 | 18.13M |
| September 13, 2024 | 16.73M |
| September 12, 2024 | 17.07M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.036M
Minimum
Nov 21 2024
243.44M
Maximum
Nov 04 2021
60.36M
Average
42.40M
Median
Market Cap Benchmarks
| Ascendis Pharma AS | 7.334B |
| DBV Technologies SA | 46.66M |
| Adaptimmune Therapeutics PLC | 162.23M |
| Akari Therapeutics PLC | 15.30M |
| Biodexa Pharmaceuticals PLC | 2.532M |
Market Cap Related Metrics
| PS Ratio | 1.898 |
| Price to Book Value | 108.60 |
| Price | 1.37 |
| Earnings Yield | -204.4% |